ProAir Digihaler in COPD Disease Management: A Real World Study

Conditions:   COPD;   COPD Exacerbation Acute Interventions:   Drug: ProAir Digihaler;   Device: Digihaler Sponsors:   Pulmonary Research Institute of Southeast Michigan;   Teva Branded Pharmaceutical Products R&D,  Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials